Hospital Vall d'Hebron-ko ikertzaileekin lankidetzan egindako argitalpenak (5)

2024

  1. Pathogenic NLRP3 mutants form constitutively active inflammasomes resulting in immune-metabolic limitation of IL-1β production

    Nature Communications, Vol. 15, Núm. 1

2023

  1. The prognostic impact of SIGLEC5-induced impairment of CD8+ T cell activation in sepsis

    eBioMedicine, Vol. 97

2022

  1. First Description of Late-Onset Autoinflammatory Disease Due to Somatic NLRC4 Mosaicism

    Arthritis and Rheumatology, Vol. 74, Núm. 4, pp. 692-699

2020

  1. Severe Autoinflammatory Manifestations and Antibody Deficiency Due to Novel Hypermorphic PLCG2 Mutations

    Journal of Clinical Immunology, Vol. 40, Núm. 7, pp. 987-1000

2014

  1. The NLRP3 inflammasome is released as a particulate danger signal that amplifies the inflammatory response

    Nature Immunology, Vol. 15, Núm. 8, pp. 738-748